Clinical trials
Phase 3 Cholangiocarcinoma trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2011 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shi Ming | 2 |
| Changhai Hospital | 1 |
| Fudan University | 1 |
| Immunitor LLC | 1 |
| Samsung Medical Center | 1 |
| Shanghai Zhongshan Hospital | 1 |
| Tata Memorial Hospital | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
| Zhengang Yuan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 10 |
| Gallbladder Neoplasms | 2 |
| Carcinoma, Hepatocellular | 1 |
| Fibrosis | 1 |
| Hepatitis | 1 |
| Liver Neoplasms | 1 |
| Neoplasms | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.